Glenmark gets India`s nod for making favipiravir for COVID-19 treatment

The Mumbai-based company said the approval was part of India`s accelerated approval process and the drug was meant for "restricted emergency use," meaning patients must sign their consent before being treated by the drug.

from Zee News :India National https://ift.tt/2Cqz0qr